Warberg Asset Management »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $781k 550k 1.42
2023-09-30 $912k 517k 1.76

More positions owned by Warberg Asset Management

Spdr S&p 500 Etf Tr Put Put Option
Occidental Pete Corp W Exp 08/03/202 (OXY.WS)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Invesco Qqq Tr Put Put Option
United States Stl Corp Note 5.000%11/0 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Interdigital Note 2.000% 6/0 (Principal)
Altair Engr Note 0.250% 6/0 (Principal)
Chart Inds Note 1.000%11/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
Hubspot Note 0.375% 6/0 (Principal)
Conmed Corp Note 2.625% 2/0 (Principal)
Repligen Corp Note 0.375% 7/1 (Principal)
RH Note 9/1 (Principal)
Akamai Technologies Note 0.125% 5/0 (Principal)

View all positions for Warberg Asset Management

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
Point72 Asset Management
D. E. Shaw & Co
CSS
Capstone Investment Advisors
Worth Venture Partners
Bank of America Corporation
Palisade Capital Management
Warberg Asset Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Fox Hill Wealth Management
Virtus Investment Advisers
Royal Bank of Canada
Citigroup

View all funds holding Sarepta Therapeutics note 1.500% 11/1